Clinical Trials Logo
  1. Home
  2. Retroperitoneal Sarcoma
  3. NCT05302570

Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS — PROTONS-RPS  

Retroperitoneal Sarcoma Clinical Trial

Official title:
PROTONS-RPS: a Phase II Non-Randomized Open-label Single-arm Trial Of Neoadjuvant Short-course Hypofractionated Proton Beam Therapy for Non-metastatic RetroPeritoneal Sarcoma

Clinical Trial Summary

The investigators' study titled "PROTONS-RPS: a Phase II non-Randomized Open-label single-arm Trial Of Neoadjuvant Short-course hypofractionated proton beam therapy for non-metastatic RetroPeritoneal Sarcoma" is a phase II trial evaluating the safety and efficacy of hypofractionated proton beam therapy (H-PBT) in the neoadjuvant (NA) setting for patients with non-metastatic retroperitoneal sarcoma (RPS) planned for surgical resection. This trial will include adult patients with resectable RPS.

Clinical Trial Description

The investigators' primary outcome is overall complication rate after treatment with NA H-PBT and surgical resection based on National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.2 Secondary objectives include evaluating the acute toxicity of H-PBT prior to surgical resection, rate of progression between diagnosis and definitive resection, early post-operative complication rate after resection of RPS in patients who received NA H-PBT, and local recurrence-free survival at 1 and 2 years. A priori subset analyses will be conducted for patients with well-differentiated and dedifferentiated liposarcoma. The investigators plan to accrue a minimum of 44 patients to evaluate the investigators' primary outcome. Treatment will be 5 doses of H-PBT including a simultaneous integrated boost to at-risk margins followed by surgical resection after 4-6 weeks. Patients will be followed in the post-operative setting according to standard of care surveillance for RPS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05302570
Study type Interventional
Source Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Contact
Status Withdrawn
Phase Phase 2
Start date December 2022
Completion date December 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03838718 - REtroperitoneal SArcoma Registry: an International Prospective Initiative
Enrolling by invitation NCT05844813 - Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma Phase 4
Terminated NCT00901836 - Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma N/A
Completed NCT05044624 - Retroperıtoneal Soft-Tıssue Sarcomas N/A
Active, not recruiting NCT04189783 - Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial) Phase 2
Completed NCT04225494 - Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas
Active, not recruiting NCT03792867 - Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma N/A
Not yet recruiting NCT06025747 - Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma Phase 1
Active, not recruiting NCT04224948 - The PET- Retroperitoneal Sarcoma Study N/A
Recruiting NCT04031677 - Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma Phase 3
Recruiting NCT05224934 - Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma Phase 2
Completed NCT03877588 - Nutritional Status in Retroperitoneal Sarcoma. N/A
Completed NCT02384473 - Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma Early Phase 1
Recruiting NCT01659203 - Proton or Photon RT for Retroperitoneal Sarcomas Phase 1/Phase 2
Recruiting NCT05631379 - Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma
Recruiting NCT06327477 - Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma Phase 1/Phase 2